Okay. Looks like its all still lumped together. Immune Pharmaceuticals, Inc. (“Immune Inc.”), Immune Pharmaceuticals, Ltd. (“Immune Ltd.”), Cytovia, Inc. (“Cytovia”), Immune Oncology Pharmaceuticals, Inc. (“Oncology”), Maxim Pharmaceuticals, Inc. (“Maxim”), and Immune Pharmaceuticals USA Corp. (“USA,” collectively with the foregoing, the “Debtors”). All the subs are still owned by Immune.